Purpose: Levetiracetam is a broad-spectrum anti-epileptic drug that is effective against both focal and generalized epilepsies. In this study, we aimed to evaluate the efficacy, tolerability and safety of levetiracetam monotherapy in the management of different seizure types in children with epilepsy under the age of two.
The FDA has approved Spritam (levetiracetam), from Aprecia Pharmaceuticals, for oral use as a prescription adjunctive therapy in the treatment...